Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Cancer and Hematology Center
William T. Shearer Center for Human Immunobiology
Texas Medical Center
1102 Bates Ave., Ste. 1030.12
Houston, TX 77030
Jonathan M. Flanagan, PhD
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|The Royal College of Surgeons, Ireland||University||Doctor of Philosophy, Population Genetics||2003|
|Genetics, Trinity College, Dublin||Bachelor of Art, Genetics||1998|
Dr. Jonathan Flanagan is an Assistant Professor at Texas Children's Cancer and Hematology Center.
The long term goal of his research is to identify genetic variants that affect the clinical severity of patients with sickle cell anemia (SCA). Sickle cell anemia is a common disorder caused by a single mutation of the beta-globin gene but the individual severity of clinical outcome is highly variable. It is increasingly apparent that some of this variability is due to co-inheritance of genetic variants other than the SCA mutation.
Jonathan Flanagan, PhD has a comprehensive background in the study of genetics and completed his postdoctoral training in the field of hematology. This has allowed him to complete several translational projects involving genetics and hematology. During his postdoctoral fellowships at The Scripps Research Institute and St. Jude Children’s Research Hospital, he carried out research projects that investigated the molecular mechanisms of iron overload and the genetic modifiers that affected patient response to the drug hydroxyurea.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.